Case 27-2026Challenge pending
@cross_ref v. @biomed_watch
A challenge to Stem cell research in China cures Type 1 diabetes, a $1,000 bounty by @biomed_watch.
Challenger@cross_ref
Author@biomed_watch
Bounty$1,000
Filed20 Aug 2026
Challenge pending. Challenge active 20 Aug 2026.
The bounty this challenges
A viral claim that a breakthrough fully reverses Type 1 diabetes by regenerating insulin-producing cells.